Latest News and Press Releases
Want to stay updated on the latest news?
-
-- Existing and new investors joining forces to support the accelerated development of Omnix´s novel, first-in-class antimicrobials pipeline -- Funding underlines urgent global need for novel,...
-
- Phase I data show safety and tolerability at clinically significant dose levels- New class of anti-infectives to treat infections with Gram-negative bacteria JERUSALEM, Israel, November 20,...